In my opinion, there is not a prospective, well-documented study showing that metformin decreases cardiovascular events as monotherapy. Evidence-based benefits Studies assessing CV outcomes with SGLT2 inhibitors, pioglitazone and GLP-1 receptor agonists are quite robust, with data showing benefits above and beyond CV outcomes, DeFronzo said
How to Use: Drop 1 effervescent tablet in 250ml water, wait till the effervescent tablets dissolves completely and drink
The Wikipedia overview of Retatrutide provides additional trial context
Effects of stopping Wegovy for MASH Because the Wegovy injection was only approved in August 2025 for the treatment of noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH), the specific effects of stopping Wegovy for this condition are unclear
With COVID, we dont have good measurement tools, so there is no effective titer to run